FunPep Announces Start of Joint Research with Crafton Biotechnology
NQ Score
47/100
N1 Content Completeness
9
AI Summary (NQ-processed)
FunPep has signed a joint research agreement with Crafton Biotechnology to develop new therapeutic mRNA vaccines by combining antibody-inducing peptide technology with mRNA technology.
AI Analysis
Frequently Asked Questions
- Q: What is the significance of the partnership between FunPep and Crafton?
- A: It aims to create next-generation vaccines by fusing peptide and mRNA technologies.